Literature DB >> 25726433

Burden of norovirus in healthcare facilities and strategies for outbreak control.

A Kambhampati1, M Koopmans2, B A Lopman3.   

Abstract

Norovirus is the most frequently occurring cause of community-acquired acute gastroenteritis in people of all ages. It is also one of the most frequent causes of outbreaks in healthcare settings, affecting both long-term care facilities and acute care hospitals. Whereas norovirus gastroenteritis is typically mild and resolves without medical attention, healthcare-associated infections often affect vulnerable populations, resulting in severe infections and disruption of healthcare services. Globally, most norovirus outbreaks in hospitals and residential care institutions are associated with genogroup II type 4 (GII.4) strains. Recent data demonstrate that excess mortality occurs during outbreak periods in healthcare facilities. Nosocomial outbreaks can result in large economic and societal costs. Current control measures for norovirus are largely based on general infection control principles, and treatment is mainly supportive and non-specific. While neither vaccines nor antiviral agents are currently available, both are being developed with encouraging results. Published by Elsevier Ltd.

Entities:  

Keywords:  Antiviral agents; Gastroenteritis; Genogroup II type 4; Infection control; Norovirus

Mesh:

Year:  2015        PMID: 25726433      PMCID: PMC4668703          DOI: 10.1016/j.jhin.2015.01.011

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  78 in total

Review 1.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review.

Authors:  Rishi Desai; Christal D Hembree; Andreas Handel; Jonathan E Matthews; Benjamin W Dickey; Sharla McDonald; Aron J Hall; Umesh D Parashar; Juan S Leon; Benjamin Lopman
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

2.  Norovirus outbreak of probable waterborne transmission with high attack rate in a Guatemalan resort.

Authors:  Wences Arvelo; Silvia M Sosa; Patricia Juliao; María R López; Alejandra Estevéz; Beatriz López; María E Morales-Betoulle; Miguel González; Nicole A Gregoricus; Aron J Hall; Jan Vinje; Umesh Parashar; Kim A Lindblade
Journal:  J Clin Virol       Date:  2012-07-07       Impact factor: 3.168

3.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis.

Authors:  Naeemah Munir; Pengbo Liu; Paul Gastañaduy; Julia Montes; Andi Shane; Christine Moe
Journal:  J Med Virol       Date:  2013-09-30       Impact factor: 2.327

5.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

6.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Prevalence and characteristics of asymptomatic norovirus infection in the community in England.

Authors:  G Phillips; C C Tam; L C Rodrigues; B Lopman
Journal:  Epidemiol Infect       Date:  2010-03-03       Impact factor: 2.451

8.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

9.  Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

Authors:  Ben Lopman; Harry Vennema; Evelyne Kohli; Pierre Pothier; Alicia Sanchez; Anabel Negredo; Javier Buesa; Eckart Schreier; Mark Reacher; David Brown; Jim Gray; Miren Iturriza; Chris Gallimore; Blenda Bottiger; Kjell-Olof Hedlund; Maria Torvén; Carl-Henrik von Bonsdorff; Leena Maunula; Mateja Poljsak-Prijatelj; Janet Zimsek; Gábor Reuter; György Szücs; Béla Melegh; Lennart Svennson; Yvonne van Duijnhoven; Marion Koopmans
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

10.  Outbreak management and implications of a nosocomial norovirus outbreak.

Authors:  Cecilia P Johnston; Haoming Qiu; John R Ticehurst; Conan Dickson; Patricia Rosenbaum; Patricia Lawson; Amy B Stokes; Charles J Lowenstein; Michael Kaminsky; Sara E Cosgrove; Kim Y Green; Trish M Perl
Journal:  Clin Infect Dis       Date:  2007-07-18       Impact factor: 9.079

View more
  24 in total

1.  Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.

Authors:  Jennifer L Cannon; Leslie Barclay; Nikail R Collins; Mary E Wikswo; Christina J Castro; Laura Cristal Magaña; Nicole Gregoricus; Rachel L Marine; Preeti Chhabra; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

2.  Molecular-Genetic Characterization of Human Rotavirus A Strains Circulating in Moscow, Russia (2009-2014).

Authors:  Victoria Kiseleva; Evgeny Faizuloev; Elena Meskina; Anna Marova; Alexey Oksanich; Tatiana Samartseva; Georgy Bakhtoyarov; Natalia Bochkareva; Nikolay Filatov; Andrey Linok; Yulia Ammour; Vitaly Zverev
Journal:  Virol Sin       Date:  2018-07-30       Impact factor: 4.327

3.  Outbreak column 18: The undervalued work of outbreak: prevention, preparedness, detection and management.

Authors:  Evonne T Curran; Catherine E Dalziel
Journal:  J Infect Prev       Date:  2015-08-12

Review 4.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

5.  The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009-2016.

Authors:  Rachel M Burke; Minesh P Shah; Mary E Wikswo; Leslie Barclay; Anita Kambhampati; Zachary Marsh; Jennifer L Cannon; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

6.  The use of military planning techniques to manage outbreaks of novel infections in acute inpatient settings: development of an 'infection control estimate' (ICE).

Authors:  Matthew Oliver Wynn; Ryan George; Mark Cole
Journal:  J Infect Prev       Date:  2020-11-12

7.  Norovirus Outbreaks in Long-term Care Facilities in the United States, 2009-2018: A Decade of Surveillance.

Authors:  Laura E Calderwood; Mary E Wikswo; Claire P Mattison; Anita K Kambhampati; Neha Balachandran; Jan Vinjé; Leslie Barclay; Aron J Hall; Umesh Parashar; Sara A Mirza
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

8.  Age-Specific Incidence Rates for Norovirus in the Community and Presenting to Primary Healthcare Facilities in the United Kingdom.

Authors:  Sarah J O'Brien; Anna L Donaldson; Miren Iturriza-Gomara; Clarence C Tam
Journal:  J Infect Dis       Date:  2016-02-01       Impact factor: 5.226

Review 9.  Tropical and travel-associated norovirus: current concepts.

Authors:  Sarah-Blythe Ballard; Mayuko Saito; Andrew J Mirelman; Caryn Bern; Robert H Gilman
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

10.  Long-term dynamics of Norovirus transmission in Japan, 2005-2019.

Authors:  Megumi Misumi; Hiroshi Nishiura
Journal:  PeerJ       Date:  2021-07-12       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.